<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>PrediLnc - Home</title>
    <style>
        /* General Styles */
        body {
            font-family: 'Montserrat', sans-serif;
            margin: 0;
            padding: 0;
            background-color: #f5f5f5;
            color: #333;
        }
        /* Header and Navigation Styles */
        header {
            background-color: #273746;
            color: #ffffff;
            padding: 50px 0;
            text-align: center;
        }
        header h1 {
            margin: 0;
            font-size: 2.5em;
            font-weight: 650;
            letter-spacing: 1px;
        }
        /* Navigation Styles */
        .navbar {
            display: flex;
            justify-content: center;
            align-items: center;
            background-color: #34495e;
            padding: 10px 10px;
            border-bottom: 2px solid #ccc;
           
        }

        .navbar a {
            text-decoration: none;
            color: #f7e9e9;
            padding: 8px 16px;
            border-radius: 4px;
            transition: background-color 0.3s ease;
        }
        /* Main Content Styles */
        .main-content {
            padding: 50px 20px;
            text-align: center;
        }
        .section-box {
            background-color: #ffffff;
            border-radius: 10px;
            box-shadow: 0 0 10px rgba(0, 0, 0, 0.1);
            padding: 30px;
            margin-bottom: 40px;
        }
        .section-heading {
            font-size: 2em;
            margin-bottom: 20px;
            color: #333333;
            text-align: center;
        }
        .feature {
            display: flex;
            align-items: center;
            padding: 20px;
            border: 1px solid #ccc;
            border-radius: 5px;
            background-color: #f9f9f9;
            margin-bottom: 20px;
        }
        .feature h3 {
            margin-top: 0;
            margin-bottom: 10px;
            color: #333333;
        }
        .feature-img {
            width: 500px;
            height: auto;
            border-radius: 5px;
            margin-right: 20px;
        }
        .feature-text {
            flex: 1;
            text-align: justify;
            color: #666666;
        }
        /* Footer Styles */
        footer {
            background-color: #333;
            color: white;
            text-align: center;
            padding: 20px 0;
        }
        .divider{
            margin: 0 30px;
            border-left: 2px solid #090404;
            height: 24px;
        }

    </style>
</head>
<body>
    <header> 
        <h1>PrediLnc - The lncRNA Disease Association Predictor</h1>
    </header>
    <nav class="navbar">
        <a href="/">Home</a>
        <span class="divider"></span>
        <a href="/about">About the Features</a>
        <span class="divider"></span>
        <a href="/evidences">Evidences</a>
        <span class="divider"></span>
        <a href="/applications">Applications</a>
        <span class="divider"></span>
        <a href="/contribute">Contribute</a>
        <span class="divider"></span>
        <a href="/about-us">About Us</a>
    </nav>
    <section class="features">
        <div class="main-content">
            <!-- lncRNA Features -->
            <div class="section-box">
                <div class="section-heading">Evidences</div>
                <div class="features-list">
                    <!-- First 4 features -->
                    <div class="feature">
                        <img src="{{ url_for('static', filename='roc.png') }}" alt="Kmer Frequency Image" class="feature-img">
                        <div class="feature-text">
                            <h3>Evidences using Performance Metrics</h3>
                            <p>
                                The developed lncRNA disease association prediction model demonstrates exceptional performance, boasting an accuracy of 96.56%. Its precision at 97.12% ensures minimal false positives, while a recall rate of 95.98% captures a significant portion of true positives. With an F1-score of 96.54%, the model maintains a balanced accuracy and precision trade-off. The Matthews Correlation Coefficient (MCC) stands strong at 93.13%, emphasizing its robustness in classification. Notably, the Area Under the Precision-Recall Curve (AUPR) impressively reaches 99.13%, highlighting the model's ability to yield high-confidence predictions. These metrics collectively underscore the reliability and efficacy of this lncRNA disease association prediction model.
                            </p>
                        </div>
                    </div>
                    <div class="feature">
                        <div class="feature-text">
                            <h3>Some strong Manual evidences from PubMed in support of PrediLnc Performance</h3>
                            <p>
                                1. Malat1 -> Esophageal Squamous Cell Carcinoma => Erratum: TGF-Î²1-Induced Upregulation of MALAT1 Promotes Kazakh's Esophageal Squamous Cell Carcinoma Invasion by EMT: Erratum (35711822)


                                <br>
                                <br>

                                2. H19 -> melanoma => Downregulation of lncRNA H19 sensitizes melanoma cells to cisplatin by regulating the miR-18b/IGF1 axis (32265386)

                                <br>
                                <br>

                                3. NORAD -> Lung Cancer => Impacts of LncRNA NORAD on the Proliferation, Apoptosis, and Chemosensitivity of Non-small Cell Lung Cancer Cells by Regulating ZNF217 through MiR-199a-3p (37653011)

                                <br>
                                <br>

                                4. LINC00963 -> osteosarcoma => The LncRNA LINC00963 facilitates osteosarcoma proliferation and invasion by suppressing miR-204-3p/FN1 axis (30975024)

                                <br>
                                <br>

                                5. BACE1-AS -> alzheimer disease => A novel synthetic derivative of biaryl guanidine as a potential BACE1 inhibitor, to treat Alzheimer's disease: In-silico, in-vitro and in-vivo evaluation (36451562)


                                <br>
                                <br>

                                6. HOXA11-AS -> Colorectal Cancer => The long non-coding RNA HOXA11-AS promotes epithelial mesenchymal transition by sponging miR-149-3p in Colorectal Cancer. (32922545)

                            </p>
                        </div>
                    </div>

                   
                    
                    
                </div>
            </div>

            
    </section>
    <!-- Footer -->
    <footer>
        <p>&copy; 2023 The Translational Biology Lab - PrediLnc. All Rights Reserved.</p>
    </footer>
</body>
</html>
